OncoDaily

Highlights from WIN Symposium by Wafik El-Deiry: Part 3 - OncoDaily Highlights from WIN Symposium by Wafik El-Deiry: Part 3 / 2025 WIN Consortium, AACR, Adriana Aguilar, American Association for Cancer Research, cancer, Fox

Highlights from WIN Symposium by Wafik El-Deiry: Part 3

@weldeiry.bsky.social

oncodaily.com/voices/win-s...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #WINSymposium

Paolo Tarantino: Datopotamab Deruxtecan Improves Outcomes in IO-Ineligible mTNBC - OncoDaily Paolo Tarantino: Datopotamab Deruxtecan Improves Outcomes in IO-Ineligible mTNBC / Breast Cancer, cancer, datopotamab deruxtecan, Datroway, ESMO25, OncoDaily,

Datopotamab Deruxtecan Improves Outcomes in IO-Ineligible mTNBC - Paolo Tarantino

@ptarantinomd.bsky.social

oncodaily.com/voices/datop...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #TNBC #BreastCancer #TROPIONBreast02 #Datroway

Applications Are Open for the Advanced Clinical Research Award in Breast Cancer - ASCO - OncoDaily Applications Are Open for the Advanced Clinical Research Award in Breast Cancer - ASCO / ACRA, Advanced Clinical Research Award, American Society of Clinical

ASCO - Applications Are Open for the Advanced Clinical Research Award in Breast Cancer

@ascocancer.bsky.social @conquercancer.bsky.social

oncodaily.com/voices/clini...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews

Darren Haywood: The COSA/IPOS Conference Is Just Around the Corner - OncoDaily Darren Haywood: The COSA/IPOS Conference Is Just Around the Corner / cancer, COSA, Darren Haywood, IPOS, OncoDaily, Oncology

The COSA/IPOS Conference Is Just Around the Corner - Darren Haywood

@drdarrenhaywood.bsky.social

oncodaily.com/voices/darre...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews

Michael Gensheimer: AI to Expand Knowledge in Oncology - OncoDaily Michael Gensheimer: AI to Expand Knowledge in Oncology / AI, cancer, Michael Gensheimer, OncoDaily, Oncology, Stanford AI Medicine Symposium

AI to Expand Knowledge in Oncology - Michael Gensheimer

@mgens.bsky.social

oncodaily.com/voices/micha...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews

OncoDaily Party Berlin 2025 The next OncoDaily Party lands in Berlin during ESMO 2025, where neon, night beats, and bold ideas collide. Expect high-energy conversations, new connections,

OncoDaily Party Berlin 2025

oncodaily.com/oncodaily-pa...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews

Europe-Wide Initiative to Improve Pediatric Oncology Support Officially Kicks Off – CCI Europe - OncoDaily Europe-Wide Initiative to Improve Pediatric Oncology Support Officially Kicks Off – CCI Europe / CCI Europe, Childhood Cancer International - Europe, DGsante,

CCI Europe - Europe-Wide Initiative to Improve Pediatric Oncology Support Officially Kicks Off

oncodaily.com/voices/pedia...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #CCIEurope

Vivek Subbiah: Smarter Trial Designs - How Project Optimus is Changing Early-Phase Cancer Research - OncoDaily Vivek Subbiah: Smarter Trial Designs - How Project Optimus is Changing Early-Phase Cancer Research / American Society of Clinical Oncology, ASCO, cancer,

Smarter Trial Designs: How Project Optimus is Changing Early-Phase Cancer Research - Vivek Subbiah

@viveksubbiah.bsky.social

oncodaily.com/voices/vivek...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews

Honoring President and Chief Medical Officer, Dr. Howard “Skip” Burris - Sarah Cannon Research Institute - OncoDaily Honoring President and Chief Medical Officer, Dr. Howard “Skip” Burris - Sarah Cannon Research Institute / cancer, David R. Spigel, Erika Hamilton, Headlines,

Sarah Cannon Research Institute - Honoring President and Chief Medical Officer, Dr. Howard “Skip” Burris

@scri.com

oncodaily.com/career/chief...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #SCRI

Datopotamab-Deruxtecan Extends Survival in Metastatic TNBC Datopotamab-Deruxtecan significantly improves overall survival versus chemotherapy in first-line metastatic triple-negative breast cancer.

Press Release: Datopotamab-Deruxtecan Demonstrates Survival Benefit in First-Line Metastatic Triple-Negative Breast Cancer

@astra-zeneca.bsky.social

oncodaily.com/oncolibrary/...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #TNBC #BreastCancer #Datroway

Highlights from WIN Symposium by Wafik El-Deiry: Part 2 - OncoDaily Highlights from WIN Symposium by Wafik El-Deiry: Part 2 / cancer, OncoDaily, Oncology, Wafik S. El-Deiry⁩, WIN Consortium, WIN symposium 2025

Highlights from WIN Symposium by Wafik El-Deiry: Part 2

@weldeiry.bsky.social

oncodaily.com/voices/win-s...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #WINSymposium

7 Common Grantwriting Mistakes - Conquer Cancer, the ASCO Foundation - OncoDaily 7 Common Grantwriting Mistakes - Conquer Cancer, the ASCO Foundation / cancer, Cancer research, Conquer Cancer, Conquer Cancer the ASCO Foundation, grants,

Conquer Cancer, the ASCO Foundation - 7 Common Grantwriting Mistakes

@conquercancer.bsky.social

oncodaily.com/voices/grant...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews

Amol Akhade: New Molecules to Look Forward to in GI Cancers at ESMO 2025  - OncoDaily Amol Akhade: New Molecules to Look Forward to in GI Cancers at ESMO 2025  / Amol Akhade, cancer, ESMO 2025, ESMO25, gastric cancer, GI oncology, OncoDaily,

New Molecules to Look Forward to in GI Cancers at ESMO 2025 - Amol Akhade

@suyogcancer.bsky.social @myesmo.bsky.social

oncodaily.com/voices/amol-...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #GIOnc #ESMO2025

Kirsty Duncan: Thanks to Everyone Running or Walking for the Run for the Cure - OncoDaily Kirsty Duncan: Thanks to Everyone Running or Walking for the Run for the Cure / cancer, Kirsty Duncan, OncoDaily, Oncology, Run for the Cure

Thanks to Everyone Running or Walking for the Run for the Cure - Kirsty Duncan

oncodaily.com/voices/run-f...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews

Herbert Loong: Discussing Roles and Practices of Molecular Tumour Boards in Era of Precision Oncology - OncoDaily Herbert Loong: Discussing Roles and Practices of Molecular Tumour Boards in Era of Precision Oncology / APODDC, cancer, Herbert Loong, molecular tumour

Discussing Roles and Practices of Molecular Tumour Boards in the Era of Precision Oncology - Herbert Loong

@herbloongmd.bsky.social

oncodaily.com/voices/herbe...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews

10 Must-Read Posts in GI Oncology This Week - OncoDaily Top updates in GI oncology — liver surgery, KRAS inhibitors, precision medicine, and translational research shaping the future of cancer care.

10 Must-Read Posts in GI Oncology This Week

oncodaily.com/oncolibrary/...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #GIOnc

Highlights from WIN Symposium by Wafik El-Deiry - OncoDaily Highlights from WIN Symposium by Wafik El-Deiry / 2025 WIN Symposium, Apostolia M Tsimberidou, Atreg Therapeutics, Bill Kaelin, cancer, Daryl Pritchard, David

Highlights from WIN Symposium by Wafik El-Deiry

@weldeiry.bsky.social

oncodaily.com/voices/win-s...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews

2025 Nobel Prize in Physiology or Medicine: Peripheral Immune Tolerance, FOXP3, and the Future of Immunotherapy - OncoDaily 2025 Nobel Prize in Physiology or Medicine: Peripheral Immune Tolerance, FOXP3, and the Future of Immunotherapy / 2025 Nobel Prize in Physiology or Medicine,

2025 Nobel Prize in Physiology or Medicine: Peripheral Immune Tolerance, FOXP3, and the Future of Immunotherapy

oncodaily.com/blog/nobel-p...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews

CINDERELLA: Why Breast Cancer Care Must Go Beyond Survival - OncoDaily CINDERELLA: Why Breast Cancer Care Must Go Beyond Survival / Breast Cancer, cancer, CINDERELLA, Headlines, Maria João Cardoso, OncoDaily, Oncology

CINDERELLA: Why Breast Cancer Care Must Go Beyond Survival

oncodaily.com/voices/cinde...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #CINDERELLA #BreastCancer

Nobel Prize in Physiology or Medicine 2025 Winners - Unraveling the Immune System - OncoDaily Nobel Prize in Physiology or Medicine 2025 Winners - Unraveling the Immune System / 2025 Nobel Prize in Physiology or Medicine, cancer, Fred Ramsdell, Mary E.

Nobel Prize in Physiology or Medicine 2025 Winners – Unraveling the Immune System

oncodaily.com/voices/fred-...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #NobelPrize #Physiology

"Multimodal AI for Clinical Decision Support" at ESMO AI and Digital Oncology Congress 2025 - OncoDaily "Multimodal AI for Clinical Decision Support" at ESMO AI and Digital Oncology Congress 2025 / cancer, ESMO, European Society for Medical Oncology, OncoDaily,

“Multimodal AI for Clinical Decision Support” at ESMO AI and Digital Oncology Congress 2025

@myesmo.bsky.social

oncodaily.com/voices/clini...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews

IASLC Launches the African Impact Grants to Support Projects that Advance Lung Cancer Research - OncoDaily IASLC Launches the African Impact Grants to Support Projects that Advance Lung Cancer Research / cancer, IASLC, International Association for the Study of

IASLC Launches the African Impact Grants to Support Projects that Advance Lung Cancer Research

@iaslc.bsky.social

oncodaily.com/voices/iaslc...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews

Olubukola Ayodele: A Series of Events on Breast Cancer Awareness, Clinical Research, and Health Equity - OncoDaily Olubukola Ayodele: A Series of Events on Breast Cancer Awareness, Clinical Research, and Health Equity / breast cancer awareness, cancer, clinical research,

A Series of Events on Breast Cancer Awareness, Clinical Research, and Health Equity - Olubukola Ayodele

@bookiephronesis.bsky.social

oncodaily.com/voices/olubu...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews

Massimo Cristofanilli: Honored to be Recognized in Stanford University-Elsevier Top 2% Scientist List - OncoDaily Massimo Cristofanilli: Honored to be Recognized in Stanford University-Elsevier Top 2% Scientist List / cancer, Elsevier, Massimo Cristofanilli, OncoDaily,

Honored to be Recognized in Stanford University-Elsevier Top 2% Scientist List - Massimo Cristofanilli

@elsevierconnect.bsky.social

oncodaily.com/voices/stanf...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews

Top 10 OncoGrants of the Week: Major Global Cancer Research Funding Calls - OncoDaily Top 10 OncoGrants of the Week: Major Global Cancer Research Funding Calls / cancer, cancer innovation, Cancer research, fellowship, IASLC, immunotherapy,

Top 10 Oncogrants of the Week: Major Global Cancer Research Funding Calls

oncodaily.com/voices/385649

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #Oncogrants

Success Rate of Chemotherapy for Lung Cancer: What Patients Need to Know in 2025 - OncoDaily Explore the success rate of chemotherapy for lung cancer, from NSCLC to SCLC, with insights on survival, response, and quality of life.

Success Rate of Chemotherapy for Lung Cancer: What Patients Need to Know in 2025

oncodaily.com/oncolibrary/...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #SuccessRate #Chemotherapy #LungCancer

NRG-LU005 Trial QOL Results at ASTRO 67th Annual Meeting At ASTRO 67, the NRG-LU005 trial reported improved long-term quality of life with atezolizumab and twice-daily radiotherapy in limited-stage SCLC.

NRG-LU005 Trial at the ASTRO 67th Annual Meeting: Atezolizumab and BID Radiotherapy in Limited-Stage SCLC

oncodaily.com/oncolibrary/...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #NRG-LU005 #ASTRO25 #SCLC

Immunotherapy Success Rate for Pancreatic Cancer: What Patients Need to Know In 2025 - OncoDaily Learn about the immunotherapy success rate for pancreatic cancer, current outcomes, rare MSI-H responses, and future directions in treatment.

Immunotherapy Success Rate for Pancreatic Cancer: What Patients Need to Know In 2025

oncodaily.com/oncolibrary/...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #Immunotherapy #SuccessRate #PancreaticCancer

Biomarkers and Dual Checkpoint Blockade in Advanced Non-Small Cell Lung Cancer Survival

oncodaily.com/oncolibrary/...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #NSCLC #LungCancer

Immunotherapy Success Rate for Ovarian Cancer: What Patients Need to Know in 2025 - OncoDaily Explore the immunotherapy success rate for ovarian cancer, key clinical results, and how new combinations are improving patient outcomes.

Immunotherapy Success Rate for Ovarian Cancer: What Patients Need to Know in 2025

oncodaily.com/oncolibrary/...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #Immunotherapy #SuccessRate #OvarianCancer